WELDIT ALL PURPOSE ADHESIVE

SECTION 2: Hazards identification

Emergency Overview Appearance, form, odor: Colorless mobile liquid with solvent odor. DANGER! EXTREMELY FLAMMABLE. Keep away from heat, sparks, open flame. EYE, SKIN, AND RESPIRATORY SYSTEM IRRITANT. Avoid skin and eye contact. Wash thoroughly after handling. Avoid breathing vapor. Use with adequate ventilation. Keep container closed when not in use.

Contains

Ketones (78-93-3 and 67-64-1) and Propylene Oxide (75-56-9) "This product contains a chemical known to the State of California to cause cancer". "This product contains a chemical known to the State of California to cause birth defects or other reproductive harm." FIRST AID: Eyes-flush with water for 15 minutes. Get immediate medical attention. Skin-remove contaminated clothing and excess contaminant, flush skin with soap and water. Inhalation-remove to fresh air. Ingestion-get immediate medical attention. See Material Safety Data Sheet for more complete information. KEEP OUT OF REACH OF CHILDREN!

Principle Routes of Exposure

Skin contact Skin absorption Eye contact Inhalation Ingestion Symptoms of acute overexposure: Skin: Moderately irritating. Prolonged or repeated liquid contact can result in defatting/ drying of skin resulting in irritation and dermatitis. Eyes: Mildly irritating. High vapor concentrations may also be irritating. Inhalation: Vapors may irritate nose, throat, respiratory tract. High vapor concentration may cause CNS depression (giddiness, headache, dizziness, nausea; in extreme cases- unconsciousness and death). Ingestion: Moderately toxic. May produce CNS depression (headache, dizziness, lethargy, weakness, personality change, poor appetite and nausea). Effects of chronic overexposure: Dermatitis may result from prolonged or repeated skin overexposures. Repeated excessive overexposures to solvents has caused liver, blood and kidney damage in laboratory animals. Propylene Oxide is an NTP and IARC carcinogen. Carcinogenicity -- OSHA regulated: No ACGIH: No National Toxicology Program: Yes International Agency for Research on Cancer: Yes Cancer-suspect constituent(s) : Propylene oxide Medical conditions which may be aggravated by exposure: Preexisting eye, skin, and respiratory disorders. Other effects: MEK has demonstrated to potentiate (shorten the time of onset) of peripheral neuropathy caused by either n-hexane or methyl n-butyl ketone. MEK by itself has not been demonstrated to cause peripheral neuropathy. MEK can potentiate the neurotoxicity of hydrocarbon compounds (n-hexane, methyl-n-butylketone, and 2,5- hexanedione) and the liver and kidney toxicity of haloalkane solvents.